Effect of ocrelizumab on vaccine responses in patients with multiple sclerosis: The VELOCE study. Bar-Or A, Calkwood JC, Chognot C, Evershed J, et al. Neurology 2020 Jul 29. pii: WNL.0000000000010380.

Read + Share

Amedeo Smart

Independent Medical Education

Bar-Or A, Calkwood JC, Chognot C, Evershed J, et al. Effect of ocrelizumab on vaccine responses in patients with multiple sclerosis: The VELOCE study. Neurology 2020 Jul 29. pii: WNL.0000000000010380.
PMID: 32727835